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Tuesday, March 3, 2009 447acharacterizing these interactions will be presented. Finally, defining the inter-
action between S100A13 and Annexin 2 peptide will give much needed insight
into the non-classical release of the signal peptide-less protein Fibroblast
Growth Factor-1
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Connexins are integral membrane proteins that oligomerize to form intercellu-
lar gap junction channels. These channels allow the passage of ions, small mol-
ecules, and second messengers that are essential for the coordination of cellular
function. Many factors have been identified to regulate the channel gating of
the major cardiac connexin, connexin43 (Cx43) and our laboratory has focused
on pH-regulation, which is a cause of ischemia-induced arrhythmias. Our pre-
vious studies have suggested that regulation of Cx43 channels results from the
association of the carboxyl-terminal domain (Cx43CT), acting as a gating par-
ticle, and the cytoplasmic loop domain (Cx43CL), acting as a receptor for the
gating particle. Recently, we have identified a synthetic peptide, RXP-E (30-
mer peptide containing a RXP sequence specifically recognized by Cx43CT,
where X represents any amino acid, and R and P correspond to arginine and
proline) that interacts with the Cx43CT and can prevent closure channel. The
question remains as to whether this peptide is involved in the disruption of
the Cx43CT/Cx43CL interaction. Using NMR, we investigated the changes
in the structure of Cx43CT with RXP-E and identified the binding site in the
first half of the Cx43CT. The identification of this new specific binding domain
was furthermore confirmed by mutagenesis. Additionally, we studied the inter-
action of Cx43CT with Cx43CL and identified a similar binding region as
RXPE, confirming the potentiality of our peptide to act as a ‘‘scaffold’’, thereby
holding the channels in its open state and reducing life threatening arrhythmias.
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In recent years, scientific community has paid great attention to characterize the
protein folding and unfolding processes. Interestingly they can exhibit wide
range of structures like oligomers and aggregates. In the present work, acidic
fibrillation of bovine alpha-lactalbumin (a-LA) was studied in presence and ab-
sence of natural small nontoxic compounds at 37C in 10mMTris/10mM NaCl
buffer, pH 2.2.
Various techniques including, ThT intensity, Congo Red absorbance, far- and
near-UV, circular dichroism (CD) and intrinsic fluorescence spectroscopy,
ANS intensity, Gel filtration, TEM microscopy, were applied to characterize
the inhibitory effect of them.
Congo Red clearly demonstrated the inhibitory effect of one of these com-
pounds in amyloidogenesis pathway. The formation of beta structures was
evidently demonstrated by CD and the instability of a-LA by intrinsic fluores-
cence and ANS intensity through analysis of nucleation step is confirmed. To
give more assurance, one of these compounds was added at different times in-
cluding 0, 12, 18, 24 and 48 hours. Our data indicated that it does not play an
important role in the stability of native a-LA. However its addition after 18
hours inhibited amyloid fibrillation.
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Influenza virus binds via its envelope protein hemagglutinin (HA) sialic acid
(SA) residues of glycoproteins on the plasma membrane of the host cell. The
affinity of a single HA-SA pair is low (103 M1) compared to the overall affin-
ity between virus and cell surface caused by multiple simultaneous interactions.
For example, the affinity between virus and erythrocytes - serving as a model
for a host cell - is about 1013 M1. Multivalency is ubiquitous in biology and
can dramatically enhance affinities. We use synthetic polymers with multiple
sialic acid moieties to investigate their inhibitory effect on virus binding andfusion. The aim of this study is to gain insights into the molecular mechanism
and the effect principles of multivalent inhibitors. Furthermore we aim to mea-
sure the accurate affinity between a virus particle and the target erythrocyte
membrane by using a new developed optical tweezers system. With this ap-
proach we are able to explore the action of multivalent inhibitors on the single
molecule level. Furthermore, we study binding of labelled virus particles to hu-
man erythrocytes using fluorescence activated cell sorting (FACS). The fusion
activity is examined by detection of fluorescence de-quenching of R 18 labeled
viruses attached to human erythrocyte ghosts.
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The majority of human immunodeficiency virus-1 (HIV-1) infections across
the world result from non-B clades. CRF01_AE is predominantly seen in
Southeast Asia and the protease differs by ~10% when compared to the clade
B protease. Polymorphisms in CRF01_AE are often associated with drug resis-
tance in the clade B protease. CRF01_AE protease has been observed to de-
velop the unique N88S mutation in response to nelfinavir (NFV) therapy which
is not commonly seen in clade B protease. We present here, structural and bind-
ing thermodynamic data on CRF01_AE protease in order to explain how se-
quence polymorphisms within CRF01_AE protease might affect its activity
as well as to explain the altered NFV resistance pathway observed in
CRF01_AE. The crystal structure of HIV-1 CRF01_AE N88S protease in com-
plex with Darunavir (DRV) was determined to a resolution of 1.76 A˚ and was
compared with the clade B protease in complex with DRV. The CRF01_AE
structure shows a significant change in the flap hinge region of the protease
when compared to the clade B structure. The Ser88 side chain in the
CRF01_AE structure is involved with a novel network of hydrogen bonds
and interacts with the side chain of Asp30. This likely disrupts a critical hydro-
gen bond required for NFV binding. Binding constants and thermodynamic pa-
rameters for CRF01_AE and clade B protease were determined by isothermal
titration calorimetry (ITC). Calorimetric data indicate that wild type
CRF01_AE protease has ten fold and two fold weaker to NFV and DRV respec-
tively when compared to clade B protease. This weakened affinity may permit
the alternative pathway for NFV resistance via N88S, which is a mutation out-
side the active site.
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In Eubacteria, the ATPase SecA transports secretory proteins across the inner
membrane using the membrane embedded channel, SecYEG. SecA drives the
preprotein through the channel in an ATP dependant manner that promotes a se-
ries of conformational changes associated with the insertion and deinsertion of
a region of SecA during the translocation cycle. To gain additional insight into
the interactions between SecA and SecYEG, an in vivo sulfhydryl labeling
technique was developed to probe monocysteine SecA mutants through the
channel during protein translocation using N-(3-maleimidylpropionyl)biocytin
(MPB). Our lab demonstrated multiple residues of SecA that are exposed to the
trans side of the membrane through the SecYEG channel. These residues,
which were located throughout most domains of SecA, resided on a single
face within the Bacillus subtilis SecA crystal structure. This provided some in-
sight into the regions of SecA that are in fluid contact with the channel. Inter-
estingly, two residues located on the opposite side of the labeled face of SecA in
the nucleotide-binding domain I (NBD-I) also labeled. In the present study, the
NBDI domain was further investigated to determine if there were other residues
in fluid contact with the SecYEG channel. Additional monocysteine SecA mu-
tants were created in the NBDI domain and analyzed using the same method-
ology. After looking at the crystal structure with the newly labeled residues, the
labeled face of SecA seemed less apparent. These results emphasize the dy-
namic nature of SecA and identified regions of SecA that may interact with
the channel. The NBDI mutants will be further analyzed using an in vivo photo-
crosslinking technique.
